Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 270.63 Million USD | -22.48% |
| 2022 | 349.12 Million USD | 0.46% |
| 2021 | 347.53 Million USD | -4.94% |
| 2020 | 365.6 Million USD | 10.55% |
| 2019 | 330.71 Million USD | 18.54% |
| 2018 | 278.99 Million USD | -1.28% |
| 2017 | 282.61 Million USD | 17.64% |
| 2016 | 240.24 Million USD | 1.91% |
| 2015 | 235.74 Million USD | 21.52% |
| 2014 | 193.99 Million USD | 24.32% |
| 2013 | 156.04 Million USD | 9.84% |
| 2012 | 142.06 Million USD | 6.94% |
| 2011 | 132.84 Million USD | 3.03% |
| 2010 | 128.93 Million USD | -1.35% |
| 2009 | 130.7 Million USD | 36.4% |
| 2008 | 95.82 Million USD | 20.53% |
| 2007 | 79.49 Million USD | 16.71% |
| 2006 | 68.11 Million USD | 8.78% |
| 2005 | 62.61 Million USD | 5.17% |
| 2004 | 59.53 Million USD | 172.2% |
| 2003 | 21.87 Million USD | 8.89% |
| 2002 | 20.08 Million USD | -12.35% |
| 2001 | 22.91 Million USD | -20.92% |
| 2000 | 28.97 Million USD | -10.84% |
| 1999 | 32.5 Million USD | 0.31% |
| 1998 | 32.4 Million USD | 12.89% |
| 1997 | 28.7 Million USD | 315.94% |
| 1996 | 6.9 Million USD | -13.75% |
| 1995 | 8 Million USD | 3.9% |
| 1994 | 7.7 Million USD | -19.79% |
| 1993 | 9.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 262.65 Million USD | -0.41% |
| 2024 Q1 | 263.74 Million USD | -2.55% |
| 2024 Q3 | 231.4 Million USD | -11.9% |
| 2023 Q2 | 328.88 Million USD | -3.01% |
| 2023 Q1 | 339.07 Million USD | -2.88% |
| 2023 FY | 270.63 Million USD | -22.48% |
| 2023 Q4 | 270.63 Million USD | -17.53% |
| 2023 Q3 | 328.15 Million USD | -0.22% |
| 2022 FY | 349.12 Million USD | 0.46% |
| 2022 Q4 | 349.12 Million USD | 0.4% |
| 2022 Q2 | 354.12 Million USD | 3.47% |
| 2022 Q1 | 342.23 Million USD | -1.52% |
| 2022 Q3 | 347.74 Million USD | -1.8% |
| 2021 Q4 | 347.53 Million USD | -1.53% |
| 2021 FY | 347.53 Million USD | -4.94% |
| 2021 Q1 | 362.25 Million USD | -0.92% |
| 2021 Q2 | 363.13 Million USD | 0.24% |
| 2021 Q3 | 352.93 Million USD | -2.81% |
| 2020 Q1 | 396.52 Million USD | 19.9% |
| 2020 Q2 | 440.52 Million USD | 11.1% |
| 2020 Q3 | 416.33 Million USD | -5.49% |
| 2020 Q4 | 365.6 Million USD | -12.19% |
| 2020 FY | 365.6 Million USD | 10.55% |
| 2019 Q2 | 287.36 Million USD | -6.29% |
| 2019 Q1 | 306.65 Million USD | 9.92% |
| 2019 Q4 | 330.71 Million USD | 3.48% |
| 2019 Q3 | 319.57 Million USD | 11.21% |
| 2019 FY | 330.71 Million USD | 18.54% |
| 2018 Q3 | 269.26 Million USD | 1.45% |
| 2018 Q2 | 265.41 Million USD | -6.65% |
| 2018 FY | 278.99 Million USD | -1.28% |
| 2018 Q1 | 284.33 Million USD | 0.61% |
| 2018 Q4 | 278.99 Million USD | 3.61% |
| 2017 Q4 | 282.61 Million USD | 3.47% |
| 2017 Q2 | 265 Million USD | 7.13% |
| 2017 Q3 | 273.13 Million USD | 3.07% |
| 2017 Q1 | 247.36 Million USD | 2.96% |
| 2017 FY | 282.61 Million USD | 17.64% |
| 2016 Q2 | 222.73 Million USD | 3.86% |
| 2016 Q3 | 231.06 Million USD | 3.74% |
| 2016 FY | 240.24 Million USD | 1.91% |
| 2016 Q1 | 214.45 Million USD | -9.03% |
| 2016 Q4 | 240.24 Million USD | 3.97% |
| 2015 Q4 | 235.74 Million USD | 5.79% |
| 2015 Q3 | 222.85 Million USD | 7.13% |
| 2015 FY | 235.74 Million USD | 21.52% |
| 2015 Q1 | 197.68 Million USD | 1.9% |
| 2015 Q2 | 208.01 Million USD | 5.22% |
| 2014 Q3 | 185.49 Million USD | 3.57% |
| 2014 Q2 | 179.09 Million USD | 2.89% |
| 2014 Q4 | 193.99 Million USD | 4.58% |
| 2014 Q1 | 174.06 Million USD | 11.55% |
| 2014 FY | 193.99 Million USD | 24.32% |
| 2013 Q1 | 141.35 Million USD | -0.5% |
| 2013 Q4 | 156.04 Million USD | -0.54% |
| 2013 Q3 | 156.88 Million USD | 5.72% |
| 2013 Q2 | 148.39 Million USD | 4.98% |
| 2013 FY | 156.04 Million USD | 9.84% |
| 2012 FY | 142.06 Million USD | 6.94% |
| 2012 Q2 | 136.37 Million USD | 2.36% |
| 2012 Q4 | 142.06 Million USD | 5.34% |
| 2012 Q3 | 134.87 Million USD | -1.1% |
| 2012 Q1 | 133.22 Million USD | 0.29% |
| 2011 FY | 132.84 Million USD | 3.03% |
| 2011 Q4 | 132.84 Million USD | 2.36% |
| 2011 Q3 | 129.78 Million USD | -1.23% |
| 2011 Q2 | 131.39 Million USD | 2.04% |
| 2011 Q1 | 128.76 Million USD | -0.14% |
| 2010 FY | 128.93 Million USD | -1.35% |
| 2010 Q2 | 124.11 Million USD | -2.46% |
| 2010 Q3 | 129.85 Million USD | 4.62% |
| 2010 Q1 | 127.24 Million USD | -2.65% |
| 2010 Q4 | 128.93 Million USD | -0.71% |
| 2009 Q3 | 96.47 Million USD | 0.54% |
| 2009 FY | 130.7 Million USD | 36.4% |
| 2009 Q2 | 95.95 Million USD | 0.62% |
| 2009 Q1 | 95.36 Million USD | -0.47% |
| 2009 Q4 | 130.7 Million USD | 35.48% |
| 2008 Q3 | 88.29 Million USD | -0.03% |
| 2008 Q4 | 95.82 Million USD | 8.53% |
| 2008 FY | 95.82 Million USD | 20.53% |
| 2008 Q1 | 82.56 Million USD | 3.86% |
| 2008 Q2 | 88.31 Million USD | 6.97% |
| 2007 Q4 | 79.49 Million USD | -2.13% |
| 2007 Q2 | 75.66 Million USD | 8.98% |
| 2007 Q1 | 69.42 Million USD | 1.93% |
| 2007 Q3 | 81.22 Million USD | 7.36% |
| 2007 FY | 79.49 Million USD | 16.71% |
| 2006 FY | 68.11 Million USD | 8.78% |
| 2006 Q2 | 66.25 Million USD | 5.67% |
| 2006 Q3 | 68.51 Million USD | 3.41% |
| 2006 Q4 | 68.11 Million USD | -0.58% |
| 2006 Q1 | 62.69 Million USD | 0.12% |
| 2005 Q2 | 59.71 Million USD | 0.4% |
| 2005 Q3 | 62.81 Million USD | 5.21% |
| 2005 Q4 | 62.61 Million USD | -0.32% |
| 2005 Q1 | 59.47 Million USD | -0.11% |
| 2005 FY | 62.61 Million USD | 5.17% |
| 2004 Q1 | 52.69 Million USD | 140.9% |
| 2004 Q4 | 59.53 Million USD | 10.12% |
| 2004 Q3 | 54.06 Million USD | 6.7% |
| 2004 Q2 | 50.67 Million USD | -3.84% |
| 2004 FY | 59.53 Million USD | 172.2% |
| 2003 Q4 | 21.87 Million USD | 10.71% |
| 2003 Q1 | 19.34 Million USD | -3.68% |
| 2003 Q2 | 18.81 Million USD | -2.75% |
| 2003 FY | 21.87 Million USD | 8.89% |
| 2003 Q3 | 19.75 Million USD | 5.01% |
| 2002 FY | 20.08 Million USD | -12.35% |
| 2002 Q4 | 20.08 Million USD | 0.8% |
| 2002 Q3 | 19.92 Million USD | -1.42% |
| 2002 Q1 | 21.1 Million USD | -7.91% |
| 2002 Q2 | 20.21 Million USD | -4.2% |
| 2001 FY | 22.91 Million USD | -20.92% |
| 2001 Q1 | 26.83 Million USD | -7.41% |
| 2001 Q2 | 25.64 Million USD | -4.44% |
| 2001 Q3 | 23.82 Million USD | -7.09% |
| 2001 Q4 | 22.91 Million USD | -3.81% |
| 2000 Q4 | 28.97 Million USD | -5.36% |
| 2000 Q1 | 32.65 Million USD | 0.48% |
| 2000 FY | 28.97 Million USD | -10.84% |
| 2000 Q2 | 32.92 Million USD | 0.84% |
| 2000 Q3 | 30.61 Million USD | -7.01% |
| 1999 Q4 | 32.5 Million USD | 2.52% |
| 1999 FY | 32.5 Million USD | 0.31% |
| 1999 Q3 | 31.7 Million USD | -0.31% |
| 1999 Q1 | 31.1 Million USD | -4.01% |
| 1999 Q2 | 31.8 Million USD | 2.25% |
| 1998 Q3 | 32.8 Million USD | 2.18% |
| 1998 Q1 | 29.9 Million USD | 4.18% |
| 1998 Q2 | 32.1 Million USD | 7.36% |
| 1998 Q4 | 32.4 Million USD | -1.22% |
| 1998 FY | 32.4 Million USD | 12.89% |
| 1997 Q3 | 8.1 Million USD | 2.53% |
| 1997 Q1 | 7.1 Million USD | -10.13% |
| 1997 FY | 28.7 Million USD | 315.94% |
| 1997 Q2 | 7.9 Million USD | 11.27% |
| 1997 Q4 | 28.7 Million USD | 254.32% |
| 1996 Q4 | 7.9 Million USD | -8.14% |
| 1996 Q2 | 9.4 Million USD | 34.29% |
| 1996 Q1 | 7 Million USD | -9.09% |
| 1996 FY | 6.9 Million USD | -13.75% |
| 1996 Q3 | 8.6 Million USD | -8.51% |
| 1995 Q3 | 8 Million USD | -12.09% |
| 1995 Q4 | 7.7 Million USD | -3.75% |
| 1995 Q1 | 6.8 Million USD | -4.23% |
| 1995 Q2 | 9.1 Million USD | 33.82% |
| 1995 FY | 8 Million USD | 3.9% |
| 1994 FY | 7.7 Million USD | -19.79% |
| 1994 Q1 | 8.6 Million USD | -7.53% |
| 1994 Q3 | 7.7 Million USD | -7.23% |
| 1994 Q4 | 7.1 Million USD | -7.79% |
| 1994 Q2 | 8.3 Million USD | -3.49% |
| 1993 FY | 9.6 Million USD | 0.0% |
| 1993 Q3 | 9.6 Million USD | 1.05% |
| 1993 Q2 | 9.5 Million USD | 0.0% |
| 1993 Q4 | 9.3 Million USD | -3.13% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -762.82% |
| BrainsWay Ltd. | 62.97 Million USD | -329.766% |
| Cerus Corporation | 197.74 Million USD | -36.857% |
| Envoy Medical, Inc. | 7.64 Million USD | -3442.304% |
| electroCore, Inc. | 16.38 Million USD | -1551.504% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -3418.357% |
| IceCure Medical Ltd | 16.41 Million USD | -1549.19% |
| Inogen, Inc. | 326.19 Million USD | 17.033% |
| OrthoPediatrics Corp. | 449.58 Million USD | 39.804% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -892.417% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1532.377% |
| MaxCyte, Inc. | 268.27 Million USD | -0.879% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -3242.244% |
| Nexalin Technology, Inc. | 3.63 Million USD | -7351.494% |
| Orthofix Medical Inc. | 925.31 Million USD | 70.752% |
| PAVmed Inc | 33.11 Million USD | -717.15% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -88.657% |
| RxSight, Inc. | 182.55 Million USD | -48.251% |
| Sight Sciences, Inc. | 166.65 Million USD | -62.394% |
| SI-BONE, Inc. | 230.42 Million USD | -17.449% |
| TELA Bio, Inc. | 78.04 Million USD | -246.751% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -7.433% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -2422.199% |
| Acutus Medical, Inc. | 53.96 Million USD | -401.542% |
| Talis Biomedical Corporation | 98.34 Million USD | -175.2% |
| Spectral AI, Inc. | 10.69 Million USD | -2431.163% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -23.775% |
| CVRx, Inc. | 115.22 Million USD | -134.864% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -361.349% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -8587.32% |
| Bioventus Inc. | 810.91 Million USD | 66.626% |
| Venus Concept Inc. | 93.65 Million USD | -188.97% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -952.019% |
| LivaNova PLC | 2.42 Billion USD | 88.861% |
| 908 Devices Inc. | 202.98 Million USD | -33.329% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 66.39% |
| Nemaura Medical Inc. | 14.56 Million USD | -1758.324% |
| NeuroPace, Inc. | 107.65 Million USD | -151.398% |
| LENSAR, Inc. | 69.58 Million USD | -288.923% |
| Apyx Medical Corporation | 79.24 Million USD | -241.535% |
| Cutera, Inc. | 346.29 Million USD | 21.848% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -544.117% |
| BioSig Technologies, Inc. | 1.79 Million USD | -14951.835% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -534.378% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 92.844% |
| Axonics, Inc. | 719.92 Million USD | 62.408% |
| Outset Medical, Inc. | 313.8 Million USD | 13.757% |
| IRIDEX Corporation | 34.43 Million USD | -685.898% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 33.131% |
| IRadimed Corporation | 92.15 Million USD | -193.667% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -5050.971% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1195.647% |
| Telesis Bio, Inc. | 70.41 Million USD | -284.36% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -75.618% |
| Varex Imaging Corporation | 1.24 Billion USD | 78.343% |
| Quipt Home Medical Corp. | 247.4 Million USD | -9.387% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2806.896% |
| Pulmonx Corporation | 178.95 Million USD | -51.232% |
| Dynatronics Corporation | 25.94 Million USD | -943.277% |
| Modular Medical, Inc. | 13.8 Million USD | -1860.107% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -2422.905% |
| Semler Scientific, Inc. | 78.06 Million USD | -246.675% |
| InMode Ltd. | 863.28 Million USD | 68.651% |
| Bruker Corporation | 4.24 Billion USD | 93.632% |
| Cytosorbents Corporation | 53.26 Million USD | -408.128% |
| DexCom, Inc. | 6.26 Billion USD | 95.68% |
| Align Technology, Inc. | 6.08 Billion USD | 95.552% |
| Viveve Medical, Inc. | 25.91 Million USD | -944.387% |
| ZimVie Inc. | 1.2 Billion USD | 77.547% |
| Movano Inc. | 9.42 Million USD | -2772.646% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 45.62% |
| Nexalin Technology, Inc. | 3.63 Million USD | -7351.494% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -361.349% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 71.592% |
| Profound Medical Corp. | 43.68 Million USD | -519.489% |
| Insulet Corporation | 2.58 Billion USD | 89.544% |
| enVVeno Medical Corporation | 48.63 Million USD | -456.455% |
| Surmodics, Inc. | 185.73 Million USD | -45.71% |
| iCAD, Inc. | 41.41 Million USD | -553.416% |
| Nuwellis, Inc. | 9.77 Million USD | -2670.031% |
| Biotricity, Inc. | 5.94 Million USD | -4454.082% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 37.519% |
| Aethlon Medical, Inc. | 8.24 Million USD | -3181.986% |
| InspireMD, Inc. | 47.64 Million USD | -468.041% |
| PAVmed Inc. | 33.11 Million USD | -717.15% |
| BIOLASE, Inc. | 35.1 Million USD | -671.009% |
| Beyond Air, Inc. | 56.96 Million USD | -375.118% |
| FONAR Corporation | 214.24 Million USD | -26.318% |
| AxoGen, Inc. | 196.82 Million USD | -37.497% |
| Vivani Medical, Inc. | 45.79 Million USD | -490.938% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 3.84% |
| Inari Medical, Inc. | 674.23 Million USD | 59.861% |
| UFP Technologies, Inc. | 404.13 Million USD | 33.034% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -1056.618% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -2747.825% |
| Tenon Medical, Inc. | 6.34 Million USD | -4165.28% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -2776.921% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -161.108% |
| AdaptHealth Corp. | 4.61 Billion USD | 94.142% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1661.354% |
| NanoVibronix, Inc. | 6.67 Million USD | -3955.019% |
| Quanterix Corporation | 425.01 Million USD | 36.324% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2806.896% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -403.717% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 84.5% |
| TransMedics Group, Inc. | 706.04 Million USD | 61.669% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -328.269% |
| NeuroMetrix, Inc. | 21.42 Million USD | -1163.193% |
| Hyperfine, Inc. | 94.19 Million USD | -187.298% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -0.741% |
| Biomerica, Inc. | 9.25 Million USD | -2824.487% |
| Bone Biologics Corporation | 3.73 Million USD | -7140.48% |
| AVITA Medical, Inc. | 144.33 Million USD | -87.496% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -5458.802% |
| Silk Road Medical, Inc | 265.3 Million USD | -2.006% |